An updated review on synthetic cathinones
- PMID: 34100120
- DOI: 10.1007/s00204-021-03083-3
An updated review on synthetic cathinones
Abstract
Cathinone, the main psychoactive compound found in the plant Catha edulis Forsk. (khat), is a β-keto analogue of amphetamine, sharing not only the phenethylamine structure, but also the amphetamine-like stimulant effects. Synthetic cathinones are derivatives of the naturally occurring cathinone that largely entered the recreational drug market at the end of 2000s. The former "legal status", impressive marketing strategies and their commercial availability, either in the so-called "smartshops" or via the Internet, prompted their large spread, contributing to their increasing popularity in the following years. As their popularity increased, the risks posed for public health became clear, with several reports of intoxications and deaths involving these substances appearing both in the social media and scientific literature. The regulatory measures introduced thereafter to halt these trending drugs of abuse have proved to be of low impact, as a continuous emergence of new non-controlled derivatives keep appearing to replace those prohibited. Users resort to synthetic cathinones due to their psychostimulant properties but are often unaware of the dangers they may incur when using these substances. Therefore, studies aimed at unveiling the pharmacological and toxicological properties of these substances are imperative, as they will provide increased expertise to the clinicians that face this problem on a daily basis. The present work provides a comprehensive review on history and legal status, chemistry, pharmacokinetics, pharmacodynamics, adverse effects and lethality in humans, as well as on the current knowledge of the neurotoxic mechanisms of synthetic cathinones.
Keywords: Adverse effects; Chemistry; Neurotoxicity; Pharmacodynamics; Pharmacokinetics; Synthetic cathinones.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Aarde SM, Taffe MA (2017) Predicting the abuse liability of entactogen-class, new and emerging psychoactive substances via preclinical models of drug self-administration. In: Baumann MH, Glennon RA, Wiley JL (eds) Neuropharmacology of new psychoactive substances (NPS). Curr Top Behav Neurosci, vol 32. Springer, Cham, pp 145–164
-
- Aarde SM, Angrish D, Barlow DJ et al (2013a) Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats. Addict Biol 18(5):786–799. https://doi.org/10.1111/adb.12038 - DOI - PubMed - PMC
-
- Aarde SM, Huang PK, Creehan KM, Dickerson TJ, Taffe MA (2013b) The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats. Neuropharmacology 71:130–140. https://doi.org/10.1016/j.neuropharm.2013.04.003 - DOI - PubMed - PMC
-
- Abbara C, Ferec S, Leroux G et al (2017) 2,5-Dimethoxy-4-chloroamphetamine, a LSD-like designer drug: clinical and analytical documentation of non-fatal exposure in five patients. Toxicol Anal Clin 29(1):82–89. https://doi.org/10.1016/j.toxac.2017.01.002 - DOI
-
- Adamowicz P, Hydzik P (2019) Fetal death associated with the use of 3,4-MDPHP and alpha-PHP. Clin Toxicol (Phila) 57(2):112–116. https://doi.org/10.1080/15563650.2018.1502443 - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
